CareRx Gets TSX Green Light to Renew Buyback Program fro 2.75% of Public Float
By Adriano MarcheseCareRx intends to renew its share repurchase program to buy back up to 2.75% of its common shares over the course of a one-year period.The Canadian pharmacy services company on Tuesday said that the Toronto Stock Exchange approved its plans to renew its normal course issuer bid t…